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nloaded froPowering the ABC multidrug exporter LmrA: How
nucleotides embrace the ion-motive force
Kelvin Agboh1, Calvin H. F. Lau1*, Yvonne S. K. Khoo1†, Himansha Singh1, Sagar Raturi1,
Asha V. Nair1‡, Julie Howard2, Marco Chiapello2, Renata Feret2, Michael J. Deery2,
Satoshi Murakami3, Hendrik W. van Veen1§
LmrA is a bacterial ATP-binding cassette (ABC) multidrug exporter that uses metabolic energy to transport ions,
cytotoxic drugs, and lipids. Voltage clamping in a Port-a-Patch was used to monitor electrical currents associated
with the transport of monovalent cationic HEPES+ by single-LmrA transporters and ensembles of transporters. In
these experiments, one proton and one chloride ion are effluxed together with each HEPES+ ion out of the inner
compartment, whereas two sodium ions are transported into this compartment. Consequently, the sodium-motive
force (interior negative and low) can drive this electrogenic ion exchange mechanism in cells under physiological
conditions. The same mechanism is also relevant for the efflux of monovalent cationic ethidium, a typical multidrug
transporter substrate. Studies in the presence of Mg-ATP (adenosine 5′-triphosphate) show that ion-coupled HEPES+
transport is associated with ATP-bound LmrA, whereas ion-coupled ethidium transport requires ATP binding and
hydrolysis. HEPES+ is highly soluble in a water-based environment, whereas ethidium has a strong preference for
residence in the water-repelling plasma membrane. We conclude that the mechanism of the ABC transporter LmrA
is fundamentally related to that of an ion antiporter that uses extra steps (ATP binding and hydrolysis) to retrieve
and transport membrane-soluble substrates from the phospholipid bilayer.h
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Adenosine 5′-triphosphate (ATP)–binding cassette (ABC) multidrug
exporters are present in plasma membranes of all organisms (1). They
can confer drug resistance on cells and affect drug pharmacokinetics
and are intensely studied in clinical investigations (2). Previous studies
on LmrA fromLactococcus lactis and itsmammalian homolog, themul-
tidrug resistance P-glycoprotein (ABCB1), highlight their ability to
transport structurally diverse amphiphilic compounds from the plasma
membrane where these compounds accumulate (3, 4). The photoaffin-
ity labeling of specific protein domains and regions in LmrA and other
multidrug efflux pumps with transported drug analogs (5–7), the selec-
tive effects of site-directed mutagenesis on the polyspecificity for drugs
(8), and the structural and biophysical observations onmultidrug efflux
pumps bound to ligands (8, 9) demonstrate that the drug efflux reaction
is based on direct protein-drug interactions. ABC transporters usually
contain two membrane domains (MDs) that form the translocation
pathway for transported substrates and two nucleotide-binding do-
mains (NBDs) that bind and hydrolyze ATP. The functional LmrA
transporter is a homodimer of two half-transporters, each containing
an N-terminal MD fused to an NBD (5, 10). The metabolic energy
for substrate transport by ABC transporters is thought to be solely
derived from ATP binding and hydrolysis, but observations on appar-
ent proton-drug symport by LmrA (11) and proton-drug antiport by
the lipid-A transporter MsbA from Escherichia coli (12) indicate that
energy coupling to these ABC exporters is more complex. In addition,macroscopic ion currents have been detected in planar phospholipid
bilayers for a truncated version of LmrA (termed LmrA-MD)
containing the MD but lacking the NBD (10). It is pivotal for our
understanding of how LmrA operates to examine the relationship be-
tween ion currents, proton-substrate cotransport, andATP dependence
in transport. Here, we applied electrophysiological and biochemical
techniques to further study the mechanism of LmrA. As it is difficult
to synchronize catalytic reactions in an ensemble of ABC transporters,
our electrophysiological experiments with single-LmrA transporters in
a phospholipid bilayer were of key importance for our ability to unravel
the sequence of steps in energy coupling. We demonstrate, for the first
time, sodium-motive force–dependent drug antiport in theATP-bound
state of LmrA and the ion stoichiometry of this reaction, and we assign
functional roles to ion coupling and nucleotide utilization in the
transport activity of this multidrug transporter.RESULTS
Ion conductance by full-length LmrA
In previouswork, purified LmrA-MD inserted in a phospholipid bilayer
showed ion conductance when probed with the tip-dip technique in an
electrophysiology rig (10). These measurements showed that Cl− and
Na+ significantly contribute to the ion current observed. The work de-
scribed here started with control experiments in which the relevance of
these observations was tested for purified full-length LmrA (LmrA-
WT) in a phospholipid bilayer in a miniaturized Nanion Port-a-Patch
setup (Fig. 1 and fig. S1). The current responses to voltage steps (mem-
brane potential) demonstrate that themere presence of LmrA-WTpro-
teins in bilayers with symmetric external and internal solutions each
containing either 10 or 100mMNaCl did not cause a significant change
in ion conductance from that of empty bilayers. However, we observed
two conditions where significant current responses were obtained at a
high frequency (82 of a total of 183 experiments). First, the imposition
of the membrane potential and an inwardly directed NaCl gradient
([NaCl]in/[NaCl]out = 10 mM/100 mM) produced noticeable ion1 of 12
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 currents for LmrA-WT–containing bilayers (Fig. 1). Consistent with
the earlier observations of LmrA-MD, Na+ could effectively be re-
placed by Li+ but only weakly by K+. With the use of SO4
2− instead
of Cl− (with Na+ maintained), there was no current response at all,
suggesting that Cl− is essential in the ion conductance. Second, at
symmetric NaCl solutions ([NaCl]in/[NaCl]out = 10 mM/10 mM)
in the presence of membrane potential as a driving force for ion
movement, the application of 5 mM Mg-ATP in the external solution
induced a current response for LmrA-WT–containing phospholipid
bilayers (Fig. 2, A to C). This response was also obtained with 5 mM
of the slowly hydrolyzable ATP analog Mg–AMP-PNP (adenylyl-
imidodiphosphate) (Fig. 2D), pointing to a role of ATP binding
rather than ATP hydrolysis in the initiation of the current. No current
response was observed when LmrA-MD (lacking the NBD) was used
instead of LmrA-WT, or when Mg-ADP (adenosine 5′-diphosphate)
replaced the Mg-ATP (Fig. 2, E and F). Thus, the imposition of mem-
brane potential with ATP binding at the NBDs in the transporter (Fig. 2)
or the simultaneous imposition of membrane potential and chemical
ion gradients (Fig. 1) can each initiate LmrA-WT–associated ion con-
ductance. Previously, nanoelectrospray mass spectrometry analysis
confirmed that LmrA-WT forms a homodimer without additional
binding partners (10). Here, liquid chromatography–tandem mass
spectrometry (LC-MS/MS) analyses of our LmrA-WT preparations
further demonstrate the absence of contaminating membrane proteins
(fig. S2 and table S1). The current responses are therefore directly linked
to native LmrA-WT protein rather than to an exogenous ion trans-
locator that is regulated by LmrA.
Determination of ion stoichiometry
To investigate the ion stoichiometry and relative directions of ATP-
induced ionmovement for LmrA-WT, themembrane potential where
the net flux of ions is zero and the ionic current is absent, also referred
to as the reversal potential (Erev), was measured as a function of theAgboh et al., Sci. Adv. 2018;4 : eaas9365 19 September 2018external concentration of single ions (Fig. 2G and data analysis S1, A to
D). An increase in the external Na+ concentration resulted in a positive
shift of Erev, whereas an increase in the external Cl
− concentration re-
sulted in a negative shift (Fig. 2G). Measurements of the concentration
dependence of these shifts demonstrate the translocation of 2Na+ ions
in antiport with 1Cl− (data analysis S1, A and B). With the previously
established symport of Cl− and H+ at a 1:1 ratio (10), analysis of the
charge balance in the ion exchange reaction and subsequent Erev mea-
surements indicate the translocation of one monovalent cationic
HEPES+ (protonated on the piperazin and sulfonate moieties) per
transport cycle (data analysis S1C). These experiments point to
2Na+/(1H+-1HEPES+-1Cl−)+ exchange with a net transmembrane
movement of one positive charge per cycle (data analysis S1D). Ion ex-
change was further examined in Erev measurements for Mg-ATP
binding–induced currents with symmetric or asymmetric buffer solu-
tions in which the Na+ and Cl− concentrations were changed simulta-
neously. Under these conditions, the observed Erev values were very
close to the calculated Erev values for 2Na
+/(1H+-1HEPES+-1Cl−)+ ex-
change (Fig. 2H and data analysis S1E) but did not match predictions
for ion transport with other stoichiometries. Thus, ion conductance by
LmrA can be described using thermodynamic driving forces for
secondary-active membrane transporters.
Ion currents associated with single-LmrA transporters
SinceATP addition to LmrA-containing lipid bilayers can elicit ion flux,
we investigated the possibility of recording single-LmrA currents (Fig. 3,
A to D). A lipid bilayer was formed after the reconstitution of 1 to
5 pmol of LmrA into giant unilamellar phospholipid vesicles. The re-
sultant bilayer was clamped at a membrane voltage of −50 mV. Similar
to the macroscopic data, the application of 5mMMg-ATP elicited cur-
rent responses with inwardly directed, downward deflections with re-
spect to the baseline (Fig. 3A). We focused on single transporter
responses by excluding sections where signal stacking was observed
(equivalent to channel stacking where more than one channel is open
at the same time). Such current responses were obtained in 34% of
our attempts (61 of a total of 179 experiments), which is excellent
given the significant dilution of LmrA protein in these experiments.
In control studies with equal amounts of protein, the E314A and EE
mutants that are inactive in proton-Cl− symport (10) never produced
observable currents in the presence of 5mMMg-ATP (Fig. 3, C andD).
To test the role of ATP binding versus ATP hydrolysis in ion transport,
experiments were performed using the adenosine triphosphatase
(ATPase)–impaired DK388 mutant (Fig. 3B) (13). The mutant exhibits
only 4% of the ATPase activity of LmrA-WT because of the deletion of
the Walker A lysine (DK388) in the NBD (14). In LC-MS/MS analyses,
our samples for this mutant protein are devoid of contaminating
membrane proteins (fig. S2 and table S2). The addition of 5 mM
Mg-ATP to lipid bilayers containing the LmrA-DK388 mutant elicited
single-transporter current responses with a significantly decreased
number of transitions per unit time (active frequency) and increased
mean time during which LmrA is transport-active (mean active time)
(Fig. 3, E toH). The results indicate that the initiation of ion exchange in
LmrA requires ATP binding, whereas termination of ion exchange
requires ATP hydrolysis; this latter step is delayed for LmrA-DK388
(Fig. 3H). This mechanism of nucleotide-dependent regulation of the
ABC transporter LmrA shows analogy to the nucleotide-dependent
gating of the mammalian cystic fibrosis transmembrane conductance
regulator Cl− channel, which represents another major class of mem-
brane proteins in the ABC superfamily.–100 –50 50 100
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Fig. 1. Current-voltage responses for different buffer compositions. LmrA-WT–
containing phospholipid bilayers were subjected to a voltage step protocol with
10-mV steps for 1 s (ranging from −100 to +100 mV) from a holding potential of
0 mV. Macroscopic currents were recorded in symmetric buffer solutions containing
10mMHEPES, 20mMEGTA, and 10mMNaCl (pH7.2, NaOH) (blue triangle) or solutions
containing asymmetric salt concentrations of 10mMin/100mMout NaCl (red circle), LiCl
(purple square), KCl (black triangle), or equimolar Na2SO4 (green diamond). Data points
(mean ± SEM) are based on at least three independent measurements.2 of 12
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 Measurements of drug-ion exchange
Given the speciation of HEPES buffer at the prevailing pH of 6.5 (data
analysis S1C), LmrA-WT transports HEPES+ in a similar micromolar
concentration range as typical multidrug transporter substrates such as
monovalent cationic ethidium (15). As we previously obtained evidence
for LmrA-mediated proton-ethidium symport (11), we examined
2Na+/(1H+-1ethidium+-1Cl−)+ exchange using proteoliposomes in
which purified LmrA was inserted in an inside-out fashion (Fig. 4)
(11). Ethidium uptake into these proteoliposomes is associated with a
fluorescence intensity enhancement due to ethidiumbinding toDNA in
the lumen. The stepwise imposition of an outwardly directed sodium-
motive force (DpNa, interior positive and high) and inwardly directed
chemical H+ and Cl− gradients (DpH and DpCl, interior alkaline and
low, respectively) strongly stimulated the accumulation of ethidium
(Fig. 4A). No ethidium transport was observed for the E314A substitu-
tion mutant of LmrA, which affects the glutamate side chain that is
essential for proton-coupled drug transport (11, 15). Ethidium transport
was also lost for the K32E R34E (EE) double mutant, in which the re-Agboh et al., Sci. Adv. 2018;4 : eaas9365 19 September 2018placement of basic residues in the N-terminal elbow helix by an acidic
side chain leads to inactivation of LmrA (Fig. 4B) (10).
We examined the role of the ATPase activity in the LmrA-mediated
ethidium ion–exchange reaction. Although the ion-coupled ethidium
transport activity was not altered following the inclusion of Mg-ATP
in the assay, the presence of the nonhydrolyzable nucleotide analog
AMP-PNP strongly inhibited ethidium transport due to nucleotide
trapping (Fig. 4A). This type of inhibition was also obtained following
ATP binding to the ATPase-deficient LmrA-DK388 mutant (Fig. 4B).
Thus, ethidium transport is ATP-binding and hydrolysis-dependent
when the nucleotide is present but is dependent on electrochemical
ion gradients in the absence of nucleotide.
LmrA-mediated ethidium ion exchange was also tested in L. lactis
cells. The exposure of LmrA-WT–expressing cells to Na+ strongly stim-
ulated the efflux of ethidium (Fig. 4, C and F). Consistent with the
electrophysiological data in Fig. 1, this effect of Na+ was also observed
with Li+ and, to a lesser extent, with K+ (Fig. 4, D and E). In accordance
to the observations in proteoliposomes (Fig. 4, A and B), no ethidiumA
C
E
50 pA
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LmrA-WT + Mg-ADP
LmrA-WT + Mg-ATP
F
LmrA-MD + Mg-ATP
LmrA-WT phospholipid bilayer
G
LmrA-WT + Mg–AMP-PNPD
H
Empty phospholipid bilayer + Mg-ATP
B
N
[e ]
Fig. 2. Ion conductance in response to nucleotide binding. (A to F) Macroscopic current responses to the imposition of the same voltage protocol as in Fig. 1, in
symmetric 10 mM HEPES, 20 mM EGTA, and 10 mM NaCl solutions (pH 7.2, NaOH) in the absence or presence of 5 mM Mg-nucleotide in the external buffer. Scale bars
in (A) are applicable to all current responses. (G) Determination of ion stoichiometry from Erev measurements. Erev was measured in the presence of 5 mM Mg-ATP as a
function of the log10 of the external concentration of single buffer components: Na
+ (black circle), Cl− (blue square), or monovalent cationic HEPES+ (red diamond). Data
points (±SEM) show the mean Erev for at least three independent measurements. The internal concentration of Na
+ and Cl− was maintained at 60 mM, and the external
concentration was raised from 60 to 100, 150, or 200 mM, with HEPES maintained at 10 mM in internal and external solutions. To measure the effect of HEPES (pH 6.5),
the internal solution contained 60 mM NaCl, 20 mM EGTA, and 10 mM HEPES. The external HEPES concentration was raised from 10 to 25, 100, or 125 mM, yielding
HEPES+ concentrations of 0.29, 0.73, 2.9, and 3.6 mM. The ion stoichiometry was determined from the slope of the linear fit using the Nernst equilibrium equation (data
analysis S1). The slope values for Na+, Cl−, and HEPES+ were 104.6 ± 5.3 mV, −59.1 ± 7.8 mV, and −51.1 ± 4.9 mV, respectively (n = 3). (H) Current-voltage relation (I-V)
response graph for LmrA-WT using symmetric solutions as listed under (A) with 5 mM Mg-ATP in the external buffer (blue trace), or asymmetric solutions containing
[Na+]in/[Na
+]out = 50 mM/100 mM and [Cl
−]in/[Cl
−]out = 50 mM/50 mM in the presence of the ATP (black trace), or containing [NaCl]in/[NaCl]out = 10 mM/150 mM
without nucleotide (red trace). The Erev for the blue, black, and red traces was −2.0 ± 1.2 mV, 37.6 ± 1.5 mV, and 66.7 ± 6.1 mV (n = 3), respectively.3 of 12
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 efflux was observed in cells for the LmrA-DK388 mutant (Fig. 4F).
Finally, LmrA-dependent ethidium resistance in lactococcal cells was
strongly enhanced in M17 growth medium (pH 7.5 rather than the
standard pH 6.9), which was supplemented with 41.7 mM Na+.
Through the enhancement of the sodium-motive force (exterior positive
and high Na+), this medium promotes Na+ uptake by LmrA. In addition,
by raising pHout to a value closer to pHin, this medium reduces the trans-
membraneproton gradient that inphysiological settingswouldopposeH+
efflux (Fig. 4, G and H). Hence, 2Na+/(1H+-1ethidium+-1Cl−)+ exchange
is directly relevant for LmrA’s ethidium transport activity in proteolipo-
somes and cells and its ability to confer ethidium resistance on cells.
Ion binding sites in LmrA
In previous studies, we identified one of the ion binding residues, E314
in TM6 (transmembrane helix 6) in each half-transporter as being im-
portant for proton and ethidium transport (10, 11, 15). In a structure
model of LmrA representing theATP-bound, outward-facing state (16),
E314 is located in the interior cavity at the dimer interface in close prox-
imity to an amide-containing face (includingQ141,N144, andN148) in
TM3. The bottom of the interior cavity near the membrane-cytoplasmAgboh et al., Sci. Adv. 2018;4 : eaas9365 19 September 2018interface contains four amide side chains, N137 (intracellular extension
of TM3) and Q211 (intracellular extension of TM4) in each half-
transporter (fig. S3), the arrangement of which resembles the arrange-
ment of key amide residues in crystallized proteins with Cl− and Na+
binding sites that lack an ionized side chain of opposite charge in the
coordination sphere (fig. S4). Specifically, a systematic search of high-
resolution structures in the Protein Data Bank (see Materials and
Methods) shows multiple examples of Na+ and Cl− binding sites in
which the ion is coordinated by three, four, or five Asn or Gln residues.
For Na+, backbone carbonyl contacts or water molecules complete the
coordination sphere (fig. S4A). For Cl−, the binding site is often com-
pleted with hydrophobic side chains, as one might expect for a polar-
izable ion (fig. S4B). Consistent with the notion that ions might bind at
the interface between the two LmrA half-transporters, most of the iden-
tified Na+ and Cl− binding sites featuring this chemical makeup are ob-
served in oligomeric proteins in which they bridge an interaction
between protomers. Hence, ATP-bound LmrA contains important
candidate locations for H+, Na+, and Cl− binding.
To analyze the importance of N137A in drug and ion transport by
LmrA, the LmrA-N137A mutant protein was expressed in the plasmaC
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Fig. 3. Ion conductance is initiated by Mg-ATP binding and terminated by ATP hydrolysis. (A to D) Single-transporter current responses to the imposition of a
membrane potential of −50 mV with symmetric solutions containing 10 mM NaCl, 50 mM KCl, 10 mM HEPES, and 20 mM EGTA (pH 7.2, NaOH) in the presence of Mg-ATP in
the external buffer. Red dashed lines refer to nonactive and active states (usually referred to as closed and open states in channel studies). All-point amplitude histograms
presented on the right of every recording were obtained using an equivalent current range for all cases (bin count = 400). Mg-ATP fails to induce single-transporter con-
ductance for transport-inactive mutants LmrA-E314E and LmrA-EE, which were inserted in the bilayer at a similar protein concentration as LmrA-WT. (E to H) Analyses of
nonactive and active time distributions from which relevant parameters are derived [*P < 0.05, ***P < 0.001, one-way analysis of variance (ANOVA)]. Inhibition of ATP hydrolysis
prolongs the time period during which ion exchange is observed.4 of 12
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 membrane of lactococcal cells at a similar level as LmrA-WT (fig. S5). In
ethidium transport experiments in cells (Fig. 5A), the efflux activity of
the N137A mutant was significantly reduced compared to LmrA-WT
and not stimulated in the presence of 100 mMNa+. The reduced ethid-Agboh et al., Sci. Adv. 2018;4 : eaas9365 19 September 2018ium transport activity of the mutant was also observed in proteolipo-
somes in which the DpNa (interior positive and high), DpH (interior
low), and DpCl (interior low) were imposed simultaneously (Fig. 5B).
In contrast, LmtA-WT showed a robust, vanadate-inhibited activity in0 100 200
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Fig. 4. Ion exchange is linked to drug transport. (A and B) Transport of ethidium (2 mM) in DNA-loaded proteoliposomes containing LmrA-WT (A) or ATPase-deficient
LmrA-DK388 or proton transport–deficient LmrA-E314A (B) in an inside-out fashion, in the absence or presence of nucleotide and/or the stepwise imposition of a sodium-
motive forceDpNa (interior positive and [Na
+]in/([Na
+]out = 100mM/1mM), chemical proton gradientDpH (pHin 8.0/pHout 6.8), and chemical chloride gradientDpCl ([Cl
− ]in/([Cl
− ]out =
50 mM/150mM). Line colors are the same as bar colors and refer to the same experimental conditions. (C to E) Effect of salts on the ethidium accumulation rate in cells with (black
circles) andwithout LmrA (white circles) as apercentageof the rate in the absenceof salts. (F) Effect of 100mMNaCl in the external buffer onethidiumefflux fromcells preloadedwith
2 mMethidium. Efflux was initiated by the addition of 25mMglucose (+Glc) as a source ofmetabolic energy. (G andH) Growth of L. lactis expressing LmrA-WT (blue trace) or
LmrA-DK388 (red trace) in the presence of 4 mMethidium in standardM17medium (pH 7.0) (G) orM17medium containing 16.7mMNaOH (pH 7.5) plus 25mMNaCl (H). The error
bars for some of the data points are too small to be displayed and are hidden behind the data point symbols. Data represent observations in three or more independent
experiments with independently prepared batches of proteoliposomes and cells. Values in histograms show significance of fluorescence levels at steady state and are expressed
as means ± SEM (***P < 0.001, ****P < 0.0001, one-way ANOVA).5 of 12
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 these proteoliposomes that was well above the empty-liposome control.
Furthermore, similar to earlier observations for LmrA-E314A (10), the
N137A mutation inhibited LmrA-dependent proton efflux in intact
cells, resulting in a diminished alkalinization of the cytosol when the
cells are exposed toNa+ (Fig. 5C). Finally, electrophysiologicalmeasure-
ments of the Erev for LmrA-N137A as a function of the external Na
+
concentration show a significant twofold reduction in the DErev/
Dlog[Na+]out slope value for the mutant compared to LmrA-WT
(58.8 ± 1.6 mV versus 104.6 ± 5.3 mV; Fig. 2D), pointing to a reduced de-
pendency of the Erev on the chemical Na
+ gradient and a change in the ion
stoichiometry for the mutant. Ion conduction by LmrA-N137A is no lon-
ger associated with the Na+-stimulated ethidium transport of LmrA-WT.DISCUSSION
Previous observations on LmrA-MD–mediated ethidium-proton
symport led to the conclusion that theMD dimer of the ABC exporter
LmrA is functional as a secondary-active multidrug translocator
(11, 15). Here, the ion-coupled reaction underlying these observations
and its ion stoichiometry were studied for the first time in detail for full-
length LmrA using electrophysiological techniques. Surprisingly, LmrA
can mediate apparent 2Na+/(1H+-1HEPES+-1Cl−)+ exchange, driven
by the sodium-motive force under physiological conditions in which
HEPES+ acts as an organic “drug-like” substrate. Early studies reported
the interaction ofmammalianABCB1withHEPES, but themechanismAgboh et al., Sci. Adv. 2018;4 : eaas9365 19 September 2018of this interaction was not resolved (17). As the chemical gradients
for Na+, Cl−, and H+ that drive HEPES+ transport also drive ethid-
ium transport in proteoliposomes, the proposed mechanism is di-
rectly relevant for LmrA-mediated ethidium transport in cells (Fig. 4).
2Na+/(1H+-1ethidium+-1Cl−)+ exchange is consistent with earlier ob-
servations on LmrA-WT of apparent proton-ethidium symport and
proton-chloride symport in proteoliposomes (data analysis S2)
(10, 11, 15) and proton and chloride efflux from lactococcal cells
(10). Given the equilibrium drug binding studies on LmrA indicating
the binding of two vinblastine molecules per LmrA dimer (5), the pro-
ton in the ion exchange reaction might be effluxed instead of a second
ethidium+ or HEPES+ molecule. In this model, substrates and protons
would compete for binding to LmrA by direct or indirect mechanisms,
as described for secondary-active multidrug transporters.
Although HEPES+ and ethidium share a common mechanism of
transport, differences were observed in the regulation by nucleotide.
In the presence of a membrane potential as a driving force for ion
translocation (Figs. 2 and 3), ATP binding initiates the ion-coupled
HEPES+-transport reaction, whereas ATP hydrolysis terminates the re-
action. Repeats of these experiments with the ATPase-deficient DK388
mutant demonstrate the positive correlation between prolonged ATP
binding and the increased lifetime of the ion exchange state (Fig. 3).
Furthermore, the current response is also initiated upon binding of
the slowly hydrolyzable nucleotide analog AMP-PNP (Fig. 2D). These
results suggest that HEPES+ transport is associated with anATP-bound0 50 100 150
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Fig. 5. N137A mutation impairs drug and ion transport by LmrA. (A) Ethidium efflux from preloaded cells containing LmrA-N137A was performed as described in
Fig. 4F and was initiated by the addition of 25 mM glucose (+Glc) as a source of metabolic energy. Transport in the absence or presence of 50 mM Na2SO4 is compared
with the Na+-stimulated activity for LmrA-WT. Line colors are the same as bar colors and refer to the same experimental conditions. (B) Ethidium transport in proteo-
liposomes was measured with artificial imposition of the same ion gradients as described in Fig. 4 (A and B). Where indicated, LmrA-WT activity was inhibited by
inclusion of 1 mM Na-vanadate in the assay buffer. (C) H+ efflux was measured in cells loaded with pH probe 5(6)-carboxyfluorescein diacetate succinimidyl ester
(CFDASE) to monitor the intracellular pH in the absence or presence of 125 mM Na2SO4 in the external buffer (based on up to nine independent measurements).
Metabolic energy was generated in the cells by the addition of glucose at t = 0 min. (D) Erev was measured as described in Fig. 2G as a function of the log10 of the
external Na+ concentration. The slope value was 58.8 ± 1.6 mV. Values in histograms show significance of fluorescence end levels and are expressed as means ± SEM
(**P < 0.01, ****P < 0.0001, one-way ANOVA).6 of 12
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 state, as shown in current structures of outward-facing MsbA (18),
Sav1866 (19), and PglK (20), as well as outward-occluded McjD (21)
in which the NBDs are dimerized because of ATP binding at the dimer
interface. In contrast to these observations for HEPES+ transport, ion-
coupled ethidium transport is inactivated in response to AMP-PNP
binding (Fig. 4A) or ADP·vanadate binding (Fig. 5B) to LmrA-WT
orATP binding to LmrA-DK388 (Fig. 4, B and F). Instead, ATP hydrol-
ysis is compulsory for the ethidium transport activity, demonstrating a
requirement for the ATP binding–induced NBD dimerization followed
by ATP hydrolysis–dependent disruption of the NBD dimer interface.
The disengagement of NBDs is observed in structures of inward-facing,
nucleotide-free MsbA (18) and Atm1 (22), ADP-bound, outward-
occluded PglK (20), and ADPbS-boundMacB (23). NBD association
anddissociation have also been observed for LmrA in distancemeasure-
ments by pulsed electron-electron double resonance (PELDOR/DEER)
spectroscopy (24). Together with cysteine cross-linking studies (25),
these distance measurements suggest a high similarity between prehy-
drolysis, transition, and posthydrolysis catalytic intermediate states of
LmrA, indicating that ATP binding triggers one major conformational
change inLmrA,while smaller rearrangements are required to complete
the transport and hydrolysis cycles. The observed stoichiometric cou-
pling between ion fluxes in LmrA is therefore most likely based on co-
operative ion binding events and rapid movements of individual amino
acid side chains rather than themovements of entire proteindomains. Pre-
vious studies have raised the awareness that fast-acting membrane trans-
porters can share functional and mechanistic features with ion channels.
Our data suggest that similar considerations are true for LmrA.
One of the remarkable differences betweenHEPES+ and ethidium is
their affinity for residence in a lipophilic environment. With partition
coefficients in an octanol-water solvent system of 1:1 × 104 for HEPES+
and 1.6 × 104:1 for ethidium (26), the ability of these compounds to
accumulate in the phospholipid bilayer is very low forHEPES+ and very
high for ethidium. By analogy to proton-motive force–dependent
Resistance-Nodulation-CellDivision (RND)–typemultidrug transport-
ers, in which the drug-binding domains contain distinct drug entry
pathways that enable access of substrates from the aqueous periplasm
and the lipophilic outer leaflet of the plasma membrane (27–29), we
propose that LmrA has an aqueous pathway for substrate transport
from the cytosol and a hydrophobic pathway for substrate transport
from the membrane. The measurements on the nucleotide dependence
of HEPES+ transport indicate that the aqueous pathway is associated
with the ATP-bound state of LmrA (Figs. 2 and 3). However, the ob-
servations on ion-coupled HEPES+ and ethidium transport in the ab-
sence of ATP (Figs. 1, 2H, and 4, A and B) suggest that the aqueous
pathway is also active in apo-LmrA. PELDOR/DEER measurements
for LmrA have shown that the ATP-bound state can be sampled in
the absence of nucleotide because of the significant orientational
distribution of NBD and MDs in LmrA’s apo state (24). In the hydro-
phobic pathway, steps in the ATP hydrolysis cycle most likely regulate
the extraction of lipid-soluble substrates from the inner leaflet of the
phospholipid bilayer and/or the delivery of these substrates into the
outer leaflet of the membrane. The data on ion-coupled ethidium
transport in the absence of ATP suggest that the hydrophobic pathway
convergeswith the aqueous pathway in the translocation route and that
small molecules such as ethidium can diffuse through the hydrophobic
pathway when the regulation by ATP is not imposed. Consistent with
the measurements of ethidium transport in proteoliposomes, LmrA-
mediated ethidium transport in metabolically active cells is dependent
on both ion coupling and ATP binding and hydrolysis (Fig. 4).Agboh et al., Sci. Adv. 2018;4 : eaas9365 19 September 2018Our findings indicate a fundamental link between the chemiosmotic
mechanisms of secondary-active transporters (30) and the transport
mechanism of LmrA and demonstrate the involvement of extra steps
(ATP binding and hydrolysis) to retrieve and transport membrane-
soluble substrates from the phospholipid bilayer. The findings highlight
novel mechanistic features of substrate translocation pathways in this
ABC transporter and provide a link to early hypotheses in which
multidrug transporters were proposed to function as (i) aqueous pores
that transport drugs from the intracellular to extracellular water phase,
(ii) hydrophobic “vacuum cleaners” that transport drugs from the
membrane to the extracellular environment, and (iii) lipid flippases that
transport drugs from the inner to the outer leaflet of the phospholipid
bilayer (31, 32). In addition to small-molecule drugs, LmrA can transport
a lipophilic phosphatidylethanolamine (PE) derivative (33) and lipid-A
(34). LmrA shares this ability with its homolog MsbA in Gram-negative
bacteria (35–37). On the basis of our observations on the LmrA-mediated
transport of lipophilic ethidium, we predict that ATP binding and hy-
drolysis regulate the translocation of lipid substrate along its route from
one membrane leaflet to the other. In the ATP-bound transporter, the
ion-coupled reaction might contribute energetically to the directional
movement of the hydrophilic head group of the lipid and/or to steps
in the transport cycle that are not directly regulated by nucleotide.
Members of the ABC superfamily share structural motifs and
features but exhibit a remarkable diversity in molecular mechanisms
(38). ABC multidrug exporters might therefore not all operate in an
identical fashion or follow a single overarching blueprint. Recent studies
on proton-drug antiport by E. coli MsbA (12) and the conservation of
residues E314 (15), N137 (fig. S6), and Q211 in ABC multidrug efflux
pumps in a variety of organisms suggest that our conclusions will be
relevant for other ABC exporters. However, a comparison of our find-
ings for LmrA andMsbA suggests that the identity of ions, directions of
ion transport, and ion stoichiometries might be protein-specific.
Understanding how nucleotides embrace the ion-motive force in
ABC transporters is important for the expansion of knowledge of the
mechanisms and evolution of these transport systems. This knowledge
will create new opportunities to impose therapeutic modulation on
these fascinating andmedically importantmembrane proteins. For dec-
ades, researchers have worked on deciphering the basic mechanisms by
which ABC transporters operate, at present time with emphasis on the
application of crystallographic and cryogenic electronmicroscopy tech-
niques. Our work highlights novel dynamic features in ABC exporters
that are not predicted in the static structural snapshots at the current
resolution. Detailed biochemical, biophysical, and electrophysiological
studies therefore remain essential for our ability to identify new princi-
ples in the mechanisms of membrane transporters.MATERIALS AND METHODS
Bacterial strain and growth conditions
N-terminal hexa-histidine–tagged wild-type LmrA and its mutants—
LmrA-MD, LmrA-K32E R34E (EE), LmrA-DK388, and LmrA-
E314A—were expressed from pNZ8048-derived plasmids in the
drug-hypersensitive L. lactis strain NZ9000 DlmrA DlmrCD using
the Nisin Controlled Gene Expression (NICE) system (10, 33, 39). The
LmrA-N137Amutant was generated by site-directed mutagenesis using
the forward primer 5′-CTCGCTTAGCTGCGGATACCACGC-3′ and
the reversed primer 5′-GCGTGGTATCCGCAGCTAAGCGAG-3′.
Cells were grown at 30°C in M17 medium (Oxoid Ltd.) supplemented
with 25 mM glucose and chloramphenicol (5 mg ml−1).7 of 12
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 Preparation of inside-out membrane vesicles
Inside-out membrane vesicles (ISOVs) were prepared as described pre-
viously (33) with modifications. Cells were grown to OD660 (optical
density at 660 nm) of 0.6 after which protein expression was induced
by the addition of nisin (1:1000). Cells were harvested by centrifugation
at 13,000g for 10min at 4°C. The cell pellet waswashed and resuspended
in 100 mM potassium HEPES (pH 7.0) at 4°C. Lysozyme (2 mg ml−1;
Sigma-Aldrich) and complete protease inhibitor mixture (Roche
Applied Science) was added, and the resultant mixture was incubated
for 30 min at 30°C. Cells were broken by passage twice through a cell
disruptor (Constant Systems) at 137.9 meganewton m−2. Subsequently,
deoxyribonuclease (DNase; 10 mg ml−1; Sigma-Aldrich) and 10 mM
MgSO4 were added, and the mixture was incubated for 30 min at
30°C. Potassium EDTA (pH 7.4) was then added to a final concentra-
tion of 15 mM. Unbroken cells and cell debris were removed by cen-
trifugation at 13,000g for 45 min at 4°C. ISOVs were harvested by
centrifugation at 125,000g for 1 hour at 4°C and resuspended to a pro-
tein concentration of about 40 mg ml−1 in 50 mM potassium HEPES
(pH 7.4) containing 10% glycerol and an EDTA-free protease inhibitor
cocktail (Roche). ISOVs were stored in 2 ml of aliquots in liquid nitro-
gen. The expression of LmrA proteins in membrane vesicles was as-
sessed on Coomassie-stained SDS–polyacrylamide gel electrophoresis
(figs. S1 and S5) and immunoblots probed with primary mouse anti-
polyhistidine tag antibody (Sigma-Aldrich, catalog no. H1029) and
secondary goat anti-mouse antibody (Sigma-Aldrich, catalog no.
A4416) used at dilutions of 1:1000 and 1:5000, respectively.
Purification of LmrA proteins
His6-tagged LmrA-WT or mutants were purified from ISOVs by af-
finity chromatography (33) with significant modifications. Mem-
brane protein was solubilized at 4°C for 2 hours in a buffer containing
50 mM potassium HEPES (pH 8.0), 0.3 M NaCl, 10% (v/v) glycerol,
1% (w/v)n-decyl-b-D-maltopyranoside (DM;Affymetrix) and0.5% (w/v)
fos-choline-12 (FC-12; Affymetrix). Unsolubilized protein was re-
moved by centrifugation at 164,000g for 40 min at 4°C. Solubilized
membrane proteins were mixed and incubated for 2 hours at 4°C with
Ni–nitrilotriacetic acid resin (10 mg of LmrA per milliliter of resin),
which was pre-equilibrated in buffer A containing 50 mM potassium
HEPES (pH 8.0), 0.1 M NaCl, 25 mM imidazole, 10% (v/v) glycerol,
0.2% (w/v) DM, and 0.1% (w/v) FC-12. Following incubation, the resin
was transferred to a gravity-flow column (Bio-Rad) and washed with
15 resin volumes of buffer A (pH 8.0) and 15 resin volumes of buffer
B [50mM imidazole (pH 7.0)]. Bound protein was eluted with buffer
C (pH 7.0) supplemented with 200 mM imidazole, and the concentra-
tion of the protein was determined using the micro bicinchoninic acid
(BCA) protein assay kit (Pierce). Eluted protein was immediately used
for reconstitution into giant unilamellar vesicles (GUVs) or directly
used in lipid bilayer recordings. All handlings were carried out at 4°C.
Mass spectrometry
Purified LmrA proteins were reduced (dithiothreitol) and alkylated
(iodoacetamide) and subjected to enzymatic digestion with chymo-
trypsin overnight at 37°C. After digestion, the supernatant was pipetted
into a sample vial and loaded onto an autosampler for automated
LC-MS/MS analysis. All LC-MS/MS experimentswere performedusing
a Dionex Ultimate 3000 RSLC nanoUPLC (Thermo Fisher Scientific
Inc.) system and a Q Exactive Orbitrap mass spectrometer (Thermo
Fisher Scientific Inc.). Separation of peptides was performed by
reverse-phase chromatography at a flow rate of 300 nl min−1 and aAgboh et al., Sci. Adv. 2018;4 : eaas9365 19 September 2018Thermo Fisher Scientific reverse-phase nano EASY-Spray column
(Thermo Fisher Scientific PepMap C18; particle size, 2 mm; pore size,
100 Å; inner diameter, 75 mm; length, 50 cm). Peptides were loaded
onto a precolumn (Thermo Fisher Scientific PepMap C18; particle
size, 5 mm; pore size, 100 Å; inner diameter, 300 mm; length, 5 mm)
from the Ultimate 3000 autosampler with 0.1% formic acid for 3min
at a flow rate of 10 ml min−1. After this period, the column valve was
switched to allow elution of peptides from the precolumn onto the
analytical column. Solvent A was water + 0.1% formic acid, and sol-
vent B was 80% acetonitrile and 20% water + 0.1% formic acid. The
linear gradient used was 2 to 40% solvent B in 30 min.
The LC eluent was sprayed into the mass spectrometer by means of
an EASY-Spray source (Thermo Fisher Scientific Inc.). All mass/charge
ratio (m/z) values of eluting ions were measured in an Orbitrap mass
analyzer set at a resolution of 70,000 and was scanned betweenm/z 380
and 1500. Data-dependent scans (top 20) were used to automatically
isolate and generate fragment ions by higher-energy collisional dissoci-
ation (HCD; normalized collision energy, 25%) in the HCD collision
cell, and measurement of the resulting fragment ions was performed
in theOrbitrap analyzer set at a resolution of 17,500. Singly charged ions
and ions with unassigned charge states were excluded from being
selected forMS/MS, and a dynamic exclusion window of 20 s was used.
After run, the data were processed using ProteinDiscoverer (version
2.1, Thermo Fisher Scientific). Briefly, all MS/MS data were converted
to Mascot generic format (mgf) files, and the files were then submitted
to theMascot search algorithm (Matrix Science) and searched against a
customized L. lactis database (IL1403 DB, 2226 sequences) containing
the His-tagged LmrA-WT and LmrA-DK388 sequences. The database
also contained common contaminant sequences (115 sequences, 38,274
residues). Variable modifications of oxidation (M), deamidation (NQ),
and carbamidomethyl were applied. The peptide and fragment mass
tolerances were set to 5 ppm and 0.1 Da, respectively. A significance
threshold value of P < 0.05 and a peptide cutoff score of 20 were also
applied. The exponentiallymodified protein abundance index (tables S1
and S2) can be used as a measure for protein abundance (40). Protein
contaminants, for which only one unique peptide sequence was identi-
fied, are considered to be nonsignificant.
Preparation of GUVs
A lipidmixture composed of 1,2-diphytanoyl-sn-glycero-3-phosphocholine
(8.5mgml−1; DPhPC;Avanti Polar Lipids) and cholesterol (0.37mgml−1;
Sigma-Aldrich) was prepared in chloroform (Sigma-Aldrich). GUVs
were prepared by the electroformationmethod (41, 42) with the Vesicle
Prep Pro equipment (Nanion). The lipid mixture (30 ml) was placed on
a glass slide [coated with conductive indium tin oxide (ITO)] and
allowed to dry. A rubber O-ring was placed around the dried lipid,
and 500 ml of 1 M sorbitol (Sigma-Aldrich) was added to the lipid film.
The second glass slide was placed on top of the ring with the ITO
coating side down, thereby allowing the conduction of current. GUVs
were generated with an alternating 6-V peak-to-peak voltage at a fre-
quency of 10 Hz for 3 hours at 40°C with a rise time of 3 min and a fall
time of 5 min.
To enable recording of transporter currents, freshly purified LmrA
proteinwas incorporated intoGUVs.GUVsweremade in 1M sorbitol
after which the suspension was supplemented with 100 mM NaCl
(42). Next, 0.5 to 2 pmol (for single-transporter measurements) or 5 to
20 pmol (for macroscopic measurements) of purified LmrA protein
were added to this mixture in a total volume of 200 ml. Elution buffer
(containing detergent) without protein was also added to additional8 of 12
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 GUV samples. The mixture was incubated at 30°C for 1 hour. Deter-
gent was subsequently removed through incubation with Biobeads
(50 mg ml−1; BioRad) for 1 hour at 20°C. Before use, the beads were
hydrated using methanol followed by ethanol and ultrapure H2O and
then pre-equilibrated in 1 M sorbitol and 100 mM NaCl.
Electrophysiological recordings
Patch-clamp experiments were conducted with the Port-a-Patch setup
(Nanion). The aperture of the borosilicate chip onwhich the phospholipid
bilayer is formedmimics the electrode tip thatmakes contactwith the cell
membrane on a large-scale electrophysiology rig. To the intracellular
side, 5 ml of intracellular solution (sterile and filtered) was added. To
the extracellular side, 20 ml of extracellular solution (sterile and filtered)
was added. Planar lipid bilayers were formed from the capture (via
suction) and subsequent bursting of GUVs on the 1-mm-diameter aper-
ture on the chip. Negative pressure (−20 to −30 mbar) was applied, and
upon the formation of a gigohm seal, excess GUVs were washed out.
I-V measurements were made by holding the lipid bilayer at 0 mV
and by applying a voltage step protocol that ranged from −100 to
+100 mV in 10-mV increments in which the external solution was
kept at zero voltage. Each sweep lasted 1 s. To examine ion transport,
ion gradients were imposed. The internal solution contained 10 mM
NaCl, 10mMHEPES, 20mMEGTA (pH 7.2, NaOH), and commen-
surate sucrose to balance the osmolality. The external solution was
initially identical to the internal solution or was asymmetric with a
NaCl concentration of 150mM. The liquid junction potentials between
the electrode and the bath solution were calculated, and the measure-
ments were compensated as required. In ion substitution experiments,
Cl− salts were used to replace all Na+ ions with either Li+ or K+. To ex-
amine the Cl− contribution to current, the internal solution was altered
to 5 mMNa2SO4, and the external solution was 45 mMNa2SO4 and
5mMNaCl [EGTA and HEPES maintained (pH 7.2)]. I-Vmeasure-
ments in response to the application of nucleotides were conducted
using symmetrical internal and external solutions composed of 10 mM
NaCl, 50 mM KCl, 10 mM HEPES, and 20 mM EGTA (pH 7.2).
Mg-nucleotide (5 mM) was added to the external solution.
By convention, we refer to themovement of positive current (that is,
cations moving from the internal to external solution) as outward. Be-
cause of the external addition of ATP, only LmrA protein that was
inserted in the lipid bilayer in an inside-out orientation, with the NBDs
facing the external compartment, was accessible to ATP binding. The
inward current is therefore equal to physiological efflux in the setting of
the cell.
Ion stoichiometry
For detection of alterations in Erev due to ion composition, the
following Nernst equation was used
Erev ¼ 1zNanNa  zClnCl  zHnH  zDnD 2:303 RT
F
log
 ½Naþout
½Naþin
 nNa
 ½Cl
‐out
½Cl‐in
 nCl

½Hþout
½Hþin
 nH
 ½D
þout
½Dþin
 nD
in which zNa, zCl, zH, and zD represent the charge of the ions and nNa,
nCl, nH, and nD are the number of each of the ions moving stoichiomet-Agboh et al., Sci. Adv. 2018;4 : eaas9365 19 September 2018rically per transport cycle. R is the gas constant 8.314 J K−1 mol−1, F is
the Faraday constant 96,485 C mol−1, and T is temperature in kelvin
(298 K). There is a linear relationship between Erev and the log10 of
the external ion concentration; the slope was used to determine the n
values (see data analysis S1). This was achieved by maintaining the in-
ternal concentration of Na+ and Cl− at 60 mM and varying the external
concentrations from60 to 100, 150, or 200mMusingNa2SO4 (tomain-
tain the Cl− concentration) or MgCl2 (to maintain the Na
+ concentra-
tion). Mg-ATP (5 mM) was added to the external solution, and all
solutions were buffered with 10 mMHEPES (pH 7.2, NaOH). Sucrose
was added to the internal solution to balance osmolality. Tomeasure the
effects ofHEPES onErev, solutions contained 10mMHEPES and 10mM
NaCl (pH 6.5, NaOH). The effect of the changes in the external HEPES
concentration was examined at 10, 25, 100, and 125 mM HEPES. The
amount of Na+ on each side of the bilayer was balanced by the addition
of Na2SO4 to the internal solution (SO4
2− is not transported).
Single-transporter currents
Steady-state single-transporter currentswere recordedwith the addition
of 1 to 50 fmol of LmrA protein to a preformed DPhPC bilayer or with
LmrA-containing GUVs. LmrA bilayers were held at −50 mV, and
Mg-ATP (or the indicated nucleotide) was applied. Both the internal
and external solutions were composed of 10 mMNaCl, 50 mM KCl,
10 mM HEPES, and 20 mM EGTA (pH 7.2), and 5 mM of the indi-
cated nucleotide was added to the external solution.Only lipid bilayers
with resistances greater than 8 gigohms were used. All measurements
were amplified (gain = 100 mV per picoampere) and low-pass–
filtered at 3 kHz (HEKA EPC10 USB; four-pole Bessel), sampled at
50 kHz, and written into digital files with Patchmaster v2x73.5 acquisi-
tion software.
Analysis of single-channel recordings
Analysis was completed on up to 1-min sections of response that repre-
sent as few active proteins as possible during a cluster of bursts (without
stacking of signals) and that required minimal processing. Current re-
cordings were transferred to theQUBClassic analysis package v2.0.0.20
(https://milesculabs.biology.missouri.edu/QuB_Downloads.html,
University at Buffalo, Buffalo, NY); the baseline was corrected, and the
datawere filtered at 1 to 2 kHz. Idealization of the recordwas completed
using the segmental K-means (43) algorithm with a dead time between
0.25 and 0.5 ms. Each conductance class produced mean amplitude,
active probability (equivalent to conventional open probability in
channelmeasurements), mean nonactive (mean closed) time, andmean
active (mean open) time. The active frequency (open frequency) was
calculated by dividing the number of events by the total time period.
Terms in italics refer to conventional ion channel parameters.
Ethidium transport in proteoliposomes
For reconstitution of LmrA proteins into liposomes, acetone and
ether-washed E. coli total lipid extract was mixed with L-a-
phosphatidylcholine (PC) at a ratio of 3:1 (w/w) according to previously
described methods (11, 33). Solvent was evaporated under N2 gas, and
lipids were hydrated in buffer D [10 mM K-HEPES buffer (pH 6.8)
containing 100 mM Na acetate, 100 mM KSCN, and 50 mM KCl]
and sonicated calf thymus DNA (1 mg ml−1; Trevigen). Subsequently,
the lipid mixture was extruded 11 times through a 400-nm poly-
carbonate filter using a 1ml of LiposoFast-Basic extruder (Avestin Europe
GmbH) to form unilamellar liposomes. These liposomes were desta-
bilized by step-wise addition of aliquots of 10% Triton X-100, and
the titration was followed at OD540. Protein was added to lipid at a
ratio of 1:50 (w/w), and the mixture was incubated for 30 min at room9 of 12
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 temperature, allowing the unidirectional reconstitution of the purified
proteins in an inside-out orientation (11). Detergent was removed using
polystyrene bio-beads (Bio-Bead SM-2, Bio-Rad). Bio-beads were first
added at 80-mg bio-beads per milliliter of liposomes, followed by incu-
bation for 2 hours at room temperature. This was followed by two sub-
sequent incubations with 8-mg bio-beads per milliliter of liposomes
for 2 and 18 hours at 4°C. Proteoliposomes were harvested by centrif-
ugation at 164,000g for 30 min, resuspended in buffer D, and incu-
bated for 20 min with DNase (10 mg ml−1) and 10 mM MgSO4.
The proteoliposomes were recentrifuged at 164,000g for 30 min and
resuspended in 100 to 200 ml of buffer D. Samples were maintained on
ice and used for the transport assays within 40 to 45 min.
Ethidium transport by LmrA proteins in response to different ion
gradients and nucleotides was measured by diluting DNA-loaded pro-
teoliposomes 100-fold to a final concentration of 20 mg of membrane
protein in 2 ml of external buffers in a 3-ml fluorescence cuvette
(5, 11, 15). External buffers used to impose gradients were as follows:
(i) buffer E [10 mM K-HEPES (pH 6.8), 50 mM K2SO4, and 50 mM
KCl] to impose a DpNa (interior positive and high) plus DpH (interior
alkaline) and (ii) buffer F [10 mM K-HEPES (pH 6.8) and 150 mM
KCl] to impose a DpNa (interior positive and high) plus DpH (interior
alkaline) plus DpCl (interior low). After 20 to 30 s of recording, ethidium
bromide (2mM)was added, and fluorescencewasmeasured as a function
of time in an LS-55B luminescence spectrometer (PerkinElmer Life
Sciences) with excitation and emission wavelengths of 500 and 580 nm
with slit widths of 10 and 5 nm. As a transport control in the absence of
ion gradients, proteoliposomes were diluted 100-fold in the buffer D in
which theywereprepared.Tomeasure the effect ofATPon the transport,
5mMMg-ATP or 5mMMg–AMP-PNPwas added before the addition
of ethidium. Where indicated, Na3-orthovanadate was included at a
1 mM concentration.
Ethidium transport in cells
In ethidium accumulation measurements, LmrA-expressing and con-
trol cells were harvested and washed three times with 50 mM KPi
(pH 7.0) containing 5 mMMgSO4 and resuspended in the same buffer
to a final OD660 of 5.0 (5). Cell suspensions were diluted 10-fold in the
same buffer supplemented with 25 mM glucose to a final volume of
2 ml in a 3-ml glass cuvette. The mixture was left for 5 min at 20°C
under mild stirring to allow cells to generate metabolic energy. The
ethidium fluorescence was measured with excitation and emission
wavelengths of 500 and 580 nm and slit widths of 5 and 10 nm, re-
spectively, in an LS-55B Luminescence Spectrometer (PerkinElmer
Life Sciences). At t = 30 s, 2 mM ethidium bromide was added, and
ethidium fluorescence was followed for 10 min. The initial ethidium
accumulation rates [arbitrary units (a.u.) per second]were determined
from the slope of the linear uptake between t = 50 and 110 s. They
are presented as a percentage of the rate in the absence of salt. In ethid-
ium efflux measurements, cells were first incubated with 0.6 mM of
the uncoupler 2,4-dinitrophenol for 40min at 30°C to deprive the cells
of metabolic energy (15). The cells were then washed three times and
resuspended in 50 mM KPi (pH 7.0) containing 5 mM MgSO4 to a
final OD660 of 5.0. The concentrated cell suspension was diluted
10-fold in the same buffer to a final volume of 2 ml in a 3-ml glass
cuvette. Ethidium bromide (2 mM)was added to the mixture, and the
ethidium fluorescence was monitored. At a fluorescence level be-
tween 140 and 150 a.u., Na+ was added where indicated, followed by
25 mM glucose to provide cells with the metabolic energy for ethid-
ium efflux.Agboh et al., Sci. Adv. 2018;4 : eaas9365 19 September 2018Ethidium resistance
Drug-hypersensitive L. lactis NZ9000 DlmrA DlmrCD cells
harboring pNZ8048-based plasmids for nisin-inducible expression
of LmrA-WT or LmrA-DK388 were grown for approximately 16 hours
at 30°C in M17 medium containing 25 mM glucose and chloram-
phenicol (5 mg ml−1). The cultures were diluted fivefold in a fresh
complete medium with continued incubation at 30°C. Once the cell
suspension had reached an OD660 of 0.4, a 1:1000 dilution of the
culture supernatant of the nisin producer L. lactisNZ9700 was added,
after which growth was continued for 1 hour. The cells were sub-
sequently diluted to an OD660 of 0.02 in a complete medium
containing nisin and with additions of NaOH and NaCl, as indicated
in the legend to Fig. 4 (G and H). The diluted cells were dispensed in
the wells of a 96-well plate to which 4 mM ethidium was added.
Growth was followed over time at OD660 at 30°C in a Versamax mi-
croplate reader (Molecular Devices).
Intracellular pH measurements
Loading of cells with 30 mM of the pH-sensitive probe CFDASE
(Molecular Probes), and measurements of proton transport were per-
formed as previously described (10).
Analysis of the protein data bank
Binding sites for Na+ or Cl− were individually identified in protein
structures determined through x-ray diffraction at resolutions of
3.0 Å or better. No two proteins with a sequence identity of 90% or
greater were included in this search. Binding sites featuring three or
more ion-coordinating Gln or Asn, and no Glu, Asp, Arg, or Lys, were
selected among all sites initially identified; other types of contact (for
example, backbone, other polar side chains, and water molecules) were
not explicitly specified in the search. A putative ion-coordinating con-
tact was considered as that for which the distance to the ion is 3.0 Å or
less in the case of Na+ and 3.5 Å or less in the case of Cl−.
Statistical information
Themeasured values in electrophysiological experiments are reported
as means ± SEM based on at least three to five independent observa-
tions. Analysiswas completedwithGraphPad 6.0h software using either
the paired Student’s t test or ANOVAwith a 95% confidence interval
for the sample mean. Significance of data obtained with whole cells
and proteoliposomes was tested by the Student’s t test for data in Fig. 3
(E to H) or ANOVA for data in Figs. 4 (A, B, and F) and 5 (A and B).
Asterisks directly above bars in the histograms refer to comparisons
with control; asterisks above lines refer to specific comparisons:
*P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001.SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/4/9/eaas9365/DC1
Fig. S1. Expression and purification of LmrA proteins.
Fig. S2. Peptide coverage maps from the Mascot LC-MS/MS database search results.
Fig. S3. Ion binding sites in LmrA.
Fig. S4. Binding sites for Na+ and Cl− in example proteins.
Fig. S5. Expression and purification of LmrA-N137A mutant protein.
Fig. S6. Conservation of residue N137 in ABC multidrug transporters.
Table S1. Mascot search results for mass spectrometry data for purified LmrA-WT.
Table S2. Mascot search results for mass spectrometry data for purified LmrA-DK388.
Table S3. Speciation of HEPES at pH 6.5 as a function of the HEPES concentration.
Data analysis S1. Determination of Erev values and ion stoichiometry.
Data analysis S2. Comparisons of ion transport models.10 of 12
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